FDA Approves Gwyn Lo (norelgestromin and ethinyl estradiol) Once-Weekly Contraceptive Patch
RegulatoryapprovedGwyn LoPositive
AI Analysis
Summary
Viatris Inc. announced FDA approval of Gwyn Lo (norelgestromin and ethinyl estradiol), a once-weekly contraceptive patch. This regulatory approval represents a significant milestone for the company's women's health portfolio.
Outcome Details
FDA approval of Gwyn Lo once-weekly contraceptive patch
Importance:8/10
Sentiment:
0.90
FDA approvalcontraceptivetransdermal patchwomen's health
Related Companies
Read the original article
Published by Drugs.com New Drug Approvals on July 29, 2026 8:07 PM